St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...
Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...
Single-ascending doses of MAR002 showed a favourable tolerability and safety profile with no drug-related safety signals ...
Introduction With the increasing prevalence of asthma in children, exercise has become an essential component of asthma management, playing a significant role in improving overall health and quality ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
A new community center has opened in Gonzales, providing a space for local youth to study, socialize and engage in ...
1d
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...
An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss when given ...
The company is also anticipating new data on its antibody-drug conjugate Trodelvy in PD-L1-high non-small cell lung cancer ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback